Login
| TI Ref No : | 517364708 |
|---|---|
| Description : | Tenders Are Invited For Ex-ante Transparency Announcement Section 130c (1) Sgb V Hemlibra (r) Active Ingredient: Emicizumab Atc Code: B02bx06.ex-ante Transparency Announcement Section 130c (1) Sgb V Hemlibra (r) Active Ingredient: Emicizumab Atc Code: B02 |
| Date : | 2025-04-28 |
| Deadline : | 2025-07-27 |
| Document Type : | Contracts |
